Stem Cell-Derived treatment tested for stroke recovery
NCT ID NCT06612710
Summary
This early-stage trial is testing the safety and initial effectiveness of an experimental treatment called NouvSoma001 for people who recently had an ischemic stroke. The treatment involves intravenous administration of tiny particles derived from human neural stem cells. The study will enroll 69 participants to determine safe dosage levels and gather preliminary data on whether the treatment helps with stroke recovery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tongji Hospital affiliated to Tongji Medical College of Huazhong University ofScience and Technology
RECRUITINGWuhan, Hubei, 430000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Conditions
Explore the condition pages connected to this study.